Correction: "Impaired virion secretion by hepatitis B virus immune escape mutants and its rescue by wild-type envelope proteins or a second-site mutation" [J Virol, 87, 4, (2013) (2352-2357)] doi 10.1128/JVI.02701-12;Impaired virion secretion by hepatitis B virus immune escape mutants and its rescue by wild-type envelope Proteins or a second-site mutation

Journal of Virology

Volumn 87, Issue 4, 2013, Pages 2352-2357

  Kwei, Karen ^a,d   Tang, Xiaoli ^a,e   Lok, Anna S ^b   Sureau, Camille ^c   Garcia, Tamako ^a,f   Li, Jisu ^a   Wands, Jack ^a   Tong, Shuping ^a  

^a BROWN UNIVERSITY   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^c INSTITUT NATIONAL DE LA TRANSFUSION SANGUINE   (France)

^d DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^e BROWN UNIVERSITY   (United States)

^f Prince George's County Public Schools   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE; DISULFIDE; HEPATITIS B SURFACE ANTIGEN; VIRUS ENVELOPE PROTEIN;

ALCOHOL ABUSE; ANTIGEN RECOGNITION; ARTICLE; CONTROLLED STUDY; DISULFIDE BOND; DNA REPLICATION; GENETIC TRANSFECTION; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HEPATOMA CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; LIVER TRANSPLANTATION; MIXED INFECTION; MOLECULAR CLONING; NONHUMAN; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN GLYCOSYLATION; PROTEIN INDUCTION; PROTEIN PROCESSING; PROTEIN SECRETION; VACCINE FAILURE; VIRION; VIRUS IMMUNITY; VIRUS INFECTIVITY; VIRUS MUTANT; VIRUS MUTATION;

EID: 84873846344     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01655-17     Document Type: Erratum

References (42)

1. Zanetti AR, Van Damme P, Shouval D. 2008. The global impact of vaccination against hepatitis B: a historical overview. Vaccine 26:6266-6273.
2. Steward MW, Partidos CD, D'Mello F, Howard CR. 1993. Specificity of antibodies reactive with hepatitis B surface antigen following immunization with synthetic peptides. Vaccine 11:1405-1414.
3. Carman WF, Zanetti AR, Karayiannis P, Waters J, Manzillo G, Tanzi E, Zuckerman AJ, Thomas HC. 1990. Vaccine-induced escape mutant of hepatitis B virus. Lancet 336:325-329.
4. Harrison TJ, Hopes EA, Oon CJ, Zanetti AR, Zuckerman AJ. 1991. Independent emergence of a vaccine-induced escape mutant of hepatitis B virus. J. Hepatol. 13(Suppl 4):S105-S107.
5. Hsu HY, Chang MH, Ni YH, Chen HL. 2004. Survey of hepatitis B surface variant infection in children 15 years after a nationwide vaccination programme in Taiwan. Gut 53:1499-1503.
6. Hsu HY, Chang MH, Ni YH, Lin HH, Wang SM, Chen DS. 1997. Surface gene mutants of hepatitis B virus in infants who develop acute or chronic infections despite immunoprophylaxis. Hepatology 26:786-791.
7. Karthigesu VD, Allison LM, Fortuin M, Mendy M, Whittle HC, Howard CR. 1994. A novel hepatitis B virus variant in the sera of immunized children. J. Gen. Virol. 75(Part 2):443-448.
8. Shahmoradi S, Yahyapour Y, Mahmoodi M, Alavian SM, Fazeli Z, Jazayeri SM. 2012. High prevalence of occult hepatitis B virus infection in children born to HBsAg-positive mothers despite prophylaxis with hepatitis B vaccination and HBIG. J. Hepatol. 57:515-521.
9. Carman WF, Trautwein C, van Deursen FJ, Colman K, Dornan E, McIntyre G, Waters J, Kliem V, Muller R, Thomas HC, Manns MP. 1996. Hepatitis B virus envelope variation after transplantation with and without hepatitis B immune globulin prophylaxis. Hepatology 24:489-493.
10. Ghany MG, Ayola B, Villamil FG, Gish RG, Rojter S, Vierling JM, Lok AS. 1998. Hepatitis B virus S mutants in liver transplant recipients who were reinfected despite hepatitis B immune globulin prophylaxis. Hepatology 27:213-222.
11. McMahon G, Ehrlich PH, Moustafa ZA, McCarthy LA, Dottavio D, Tolpin MD, Nadler PI, Ostberg L. 1992. Genetic alterations in the gene encoding the major HBsAg: DNA and immunological analysis of recurrent HBsAg derived from monoclonal antibody-treated liver transplant patients. Hepatology 15:757-766.
12. Protzer-Knolle U, Naumann U, Bartenschlager R, Berg T, Hopf U, Meyer Zum Buschenfelde KH, Neuhaus P, Gerken G. 1998. Hepatitis B virus with antigenically altered hepatitis B surface antigen is selected by high-dose hepatitis B immune globulin after liver transplantation. Hepatology 27:254-263.
13. Shields PL, Owsianka A, Carman WF, Boxall E, Hubscher SG, Shaw J, O'Donnell K, Elias E, Mutimer DJ. 1999. Selection of hepatitis B surface "escape" mutants during passive immune prophylaxis following liver transplantation: potential impact of genetic changes on polymerase protein function. Gut 45:306-309.
14. Terrault NA, Zhou S, McCory RW, Pruett TL, Lake JR, Roberts JP, Ascher NL, Wright TL. 1998. Incidence and clinical consequences of surface and polymerase gene mutations in liver transplant recipients on hepatitis B immunoglobulin. Hepatology 28:555-561.
15. Chiou HL, Lee TS, Kuo J, Mau YC, Ho MS. 1997. Altered antigenicity of 'a' determinant variants of hepatitis B virus. J. Gen. Virol. 78(Part 10): 2639-2645.
16. Cooreman MP, van Roosmalen MH, te Morsche R, Sunnen CMG, de Ven EM, Jansen JB, Tytgat GN, de Wit PL, Paulij WP. 1999. Characterization of the reactivity pattern of murine monoclonal antibodies against wild-type hepatitis B surface antigen to G145R and other naturally occurring "a" loop escape mutations. Hepatology 30:1287-1292.
17. Seddigh-Tonekaboni S, Waters JA, Jeffers S, Gehrke R, Ofenloch B, Horsch A, Hess G, Thomas HC, Karayiannis P. 2000. Effect of variation in the common "a" determinant on the antigenicity of hepatitis B surface antigen. J. Med. Virol. 60:113-121.
18. Waters JA, Kennedy M, Voet P, Hauser P, Petre J, Carman W, Thomas HC. 1992. Loss of the common "A" determinant of hepatitis B surface antigen by a vaccine-induced escape mutant. J. Clin. Invest. 90:2543-2547.
19. Jeantet D, Chemin I, Mandrand B, Tran A, Zoulim F, Merle P, Trepo C, Kay A. 2004. Cloning and expression of surface antigens from occult chronic hepatitis B virus infections and their recognition by commercial detection assays. J. Med. Virol. 73:508-515.
20. Minuk GY, Sun DF, Uhanova J, Zhang M, Caouette S, Nicolle LE, Gutkin A, Doucette K, Martin B, Giulivi A. 2005. Occult hepatitis B virus infection in a North American community-based population. J. Hepatol. 42:480-485.
21. Wands JR, Marciniak RA, Isselbacher KJ, Varghese M, Don G, Halliday JW, Powell LW. 1982. Demonstration of previously undetected hepatitis B viral determinants in an Australian Aboriginal population by monoclonal anti-hbs antibody radioimmunoassays. Lancet i:977-980.
22. Weinberger KM, Bauer T, Bohm S, Jilg W. 2000. High genetic variability of the group-specific a-determinant of hepatitis B virus surface antigen (HBsAg) and the corresponding fragment of the viral polymerase in chronic virus carriers lacking detectable HBsAg in serum. J. Gen. Virol. 81:1165-1174.
23. Zaaijer HL, Torres P, Ontanon A, Ponte LG, Koppelman MH, Lelie PN, Hemert FJ, Boot HJ. 2008. Multiple surface antigen mutations in five blood donors with occult hepatitis B virus infection. J. Med. Virol. 80: 1344-1349.
24. Wilson JN, Nokes DJ, Carman WF. 1998. Current status of HBV vaccine escape variants-a mathematical model of their epidemiology. J. Viral Hepat. 5(Suppl 2):25-30.
25. Zuckerman AJ. 2000. Effect of hepatitis B virus mutants on efficacy of vaccination. Lancet 355:1382-1384.
26. Hsu HY, Chang MH, Ni YH, Chiang CL, Chen HL, Wu JF, Chen PJ. 2010. No increase in prevalence of hepatitis B surface antigen mutant in a population of children and adolescents who were fully covered by universal infant immunization. J. Infect. Dis. 201:1192-1200.
27. Kamili S, Araujo A, Fields H, Khudyakov Y, Krawczynski K, Locarinini S, Spelbring J, Trautwein C, Yokosawa J. 2002. Experimental infection of chimpanzees with genetically engineered S-gene mutants of hepatitis B virus. Hepatology 36:313A.
28. Ogata N, Zanetti AR, Yu M, Miller RH, Purcell RH. 1997. Infectivity and pathogenicity in chimpanzees of a surface gene mutant of hepatitis B virus that emerged in a vaccinated infant. J. Infect. Dis. 175:511-523.
29. Ito K, Qin Y, Guarnieri M, Garcia T, Kwei K, Mizokami M, Zhang J, Li J, Wands JR, Tong S. 2010. Impairment of hepatitis B virus virion secretion by single-amino-acid substitutions in the small envelope protein and rescue by a novel glycosylation site. J. Virol. 84:12850-12861.
30. Kalinina T, Iwanski A, Will H, Sterneck M. 2003. Deficiency in virion secretion and decreased stability of the hepatitis B virus immune escape mutant G145R. Hepatology 38:1274-1281.
31. Khan N, Guarnieri M, Ahn SH, Li J, Zhou Y, Bang G, Kim KH, Wands JR, Tong S. 2004. Modulation of hepatitis B virus secretion by naturally occurring mutations in the S gene. J. Virol. 78:3262-3270.
32. Garcia T, Li J, Sureau C, Ito K, Qin Y, Wands J, Tong S. 2009. Drastic reduction in the production of subviral particles does not impair hepatitis B virus virion secretion. J. Virol. 83:11152-11165.
33. Le Duff Y, Blanchet M, Sureau C. 2009. The pre-S1 and antigenic loop infectivity determinants of the hepatitis B virus envelope proteins are functionally independent. J. Virol. 83:12443-12451.
34. El Chaar M, Candotti D, Crowther RA, Allain JP. 2010. Impact of hepatitis B virus surface protein mutations on the diagnosis of occult hepatitis B virus infection. Hepatology 52:1600-1610.
35. Mangold CM, Unckell F, Werr M, Streeck RE. 1995. Secretion and antigenicity of hepatitis B virus small envelope proteins lacking cysteines in the major antigenic region. Virology 211:535-543.
36. Beckebaum S, Malago M, Dirsch O, Cicinnati VR, Trippler M, Lampertico P, Lama N, Treichel U, Gerken G, Broelsch CE. 2003. Efficacy of combined lamivudine and adefovir dipivoxil treatment for severe HBV graft reinfection after living donor liver transplantation. Clin. Transplant. 17:554-559.
37. Cheung WI, Chan HL, Leung VK, Tse CH, Fung K, Lin SY, Wong A, Wong VW, Chau TN. 2010. Reactivation of hepatitis B virus infection with persistently negative HBsAg on three HBsAg assays in a lymphoma patient undergoing chemotherapy. J. Clin. Virol. 47:193-195.
38. Hou J, Wang Z, Cheng J, Lin Y, Lau GK, Sun J, Zhou F, Waters J, Karayiannis P, Luo K. 2001. Prevalence of naturally occurring surface gene variants of hepatitis B virus in nonimmunized surface antigennegative Chinese carriers. Hepatology 34:1027-1034.
39. Jongerius JM, Wester M, Cuypers HT, van Oostendorp WR, Lelie PN, van der Poel CL, van Leeuwen EF. 1998. New hepatitis B virus mutant form in a blood donor that is undetectable in several hepatitis B surface antigen screening assays. Transfusion 38:56-59.
40. Kato J, Hasegawa K, Torii N, Yamauchi K, Hayashi N. 1996. A molecular analysis of viral persistence in surface antigen-negative chronic hepatitis B. Hepatology 23:389-395.
41. Salisse J, Sureau C. 2009. A function essential to viral entry underlies the hepatitis B virus "a" determinant. J. Virol. 83:9321-9328.
42. Song BC, Kim SH, Kim H, Ying YH, Kim HJ, Kim YJ, Yoon JH, Lee HS, Cha CY, Kook YH, Kim BJ. 2005. Prevalence of naturally occurring surface antigen variants of hepatitis B virus in Korean patients infected chronically. J. Med. Virol. 76:194-202.